Dianabol and Proviron Interaction: Avoid | Peptide Database

Join others researching Tretinoin — share findings, ask questions, and learn from real experiences Tretinoin is the gold standard topical retinoid for skin aging and acne, FDA-approved since 1971 for acne vulgaris and later for the treatment of photoaging (fine wrinkles, mottled hyperpigmentation, roughness). As the acid form of vitamin A, it is the most extensively studied topical anti-aging compound in dermatology, backed by decades of clinical evidence. Tretinoin accelerates epidermal cell turnover, stimulates collagen synthesis in the dermis, and improves the overall architecture of photodamaged skin. It has become a cornerstone of the biohacking and skincare optimization community due to its proven ability to reduce fine lines, even out skin tone, and improve skin texture with consistent long-term use. Tretinoin binds to retinoic acid receptors (RARs) in the cell nucleus, specifically RAR-alpha, RAR-beta, and RAR-gamma, which form heterodimers with retinoid X receptors (RXRs). These activated receptor complexes bind to retinoic acid response elements (RAREs) in DNA, modulating the transcription of genes involved in cellular differentiation, proliferation, and apoptosis. In the epidermis, tretinoin accelerates keratinocyte turnover from the typical 28-day cycle to approximately 14-16 days, promoting the shedding of damaged surface cells and their replacement with newer, healthier cells. In the dermis, tretinoin stimulates fibroblast activity, increasing the production of procollagen I and III, fibronectin, and elastin. It also inhibits matrix metalloproteinases (MMPs) that degrade collagen, and promotes angiogenesis, improving dermal blood supply. The net result is thicker, more organized epidermis, increased dermal collagen density, and reduced fine wrinkling.

Join others researching Ovagen — share findings, ask questions, and learn from real experiences Ovagen is a Khavinson bioregulator tripeptide (EDL) with primary effects on the liver and gastrointestinal tract. Developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it reduces long-term liver fibrosis and protects the GI mucosal layer from antibiotics, environmental toxins, and chemotherapy. Like other bioregulators, Ovagen crosses cell and nuclear membranes to directly regulate DNA transcription patterns with tissue-specific effects. Ovagen works through epigenetic regulation by crossing cell and nuclear membranes to directly regulate DNA structure and transcription patterns. It is transported into cells via POT family transporters (PEPT1, PEPT2) that specifically handle di- and tripeptides, explaining its precise tissue targeting. The peptide has tissue-specific effects on liver and GI tract, reducing fibrosis and protecting mucosal integrity.